how many americans are on semaglutide Insurance coverage just changed for as as 56 million when it comes to the popular GLP-1 medications used to promote weight loss. https://www.wkrg.com/news/glp-1-insurance-change-impacts-millions-of- americans-what-to-know-how-to-tell-if New Survey: GLP-1 Awareness Brings

What the Clinical Data Actually Shows The most definitive comparison comes from the SURMOUNT-5 trial, a direct head-to-head study published in the New England Journal of Medicine comparing tirzepatide 10 mg and 15 mg against semaglutide 2.4 mg in adults with obesity but without diabetes

Both Eli Lilly and Novo Nordisk have launched their own platformsLillyDirect and NovoCareto market treatments directly to patients

GLP-1 medications explained: Benefits, risks, and how they work

Diabetes Ther (2015) 6(1):2940.10.1007/s13300-015-0098-y 101 NishioSAbeMItoH

We accept most major insurance plans for office visits and lab work